BMS-582949

DB12696InvestigationalSmall molecule

BMS-582949 has been investigated for the treatment of Psoriasis.

Mechanism: Pharmacologically active on Mitogen-activated protein kinase 14
Curator reviewed
Formula / weight: C₂₂H₂₆N₆O₂ · 406.4808 g/mol (avg)
Code names: BMS-582949 · PS-540446

Resolves to

Compound

Structure

InChIKeyGDTQLZHHDRRBEB-UHFFFAOYSA-NSMILESCCCNC(=O)C1=CN2N=CN=C(NC3=CC(=CC=C3C)C(=O)NC3CC3)C2=C1C

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with BMS-582949, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.